Logo image of PLSE

PULSE BIOSCIENCES INC (PLSE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:PLSE - US74587B1017 - Common Stock

14.55 USD
+0.19 (+1.32%)
Last: 1/22/2026, 8:00:00 PM
14.55 USD
0 (0%)
After Hours: 1/22/2026, 8:00:00 PM
Fundamental Rating

2

Taking everything into account, PLSE scores 2 out of 10 in our fundamental rating. PLSE was compared to 186 industry peers in the Health Care Equipment & Supplies industry. While PLSE has a great health rating, there are worries on its profitability. PLSE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • PLSE had negative earnings in the past year.
  • In the past year PLSE has reported a negative cash flow from operations.
  • PLSE had negative earnings in each of the past 5 years.
  • PLSE had a negative operating cash flow in each of the past 5 years.
PLSE Yearly Net Income VS EBIT VS OCF VS FCFPLSE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

  • The Return On Assets of PLSE (-68.71%) is worse than 72.04% of its industry peers.
  • PLSE's Return On Equity of -80.62% is in line compared to the rest of the industry. PLSE outperforms 41.40% of its industry peers.
Industry RankSector Rank
ROA -68.71%
ROE -80.62%
ROIC N/A
ROA(3y)-62.31%
ROA(5y)-85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PLSE Yearly ROA, ROE, ROICPLSE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K 2K 2.5K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for PLSE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PLSE Yearly Profit, Operating, Gross MarginsPLSE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2K -4K -6K -8K

8

2. Health

2.1 Basic Checks

  • PLSE has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, PLSE has more shares outstanding
  • PLSE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PLSE Yearly Shares OutstandingPLSE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PLSE Yearly Total Debt VS Total AssetsPLSE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 29.70 indicates that PLSE is not in any danger for bankruptcy at the moment.
  • PLSE has a Altman-Z score of 29.70. This is amongst the best in the industry. PLSE outperforms 97.31% of its industry peers.
  • PLSE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 29.7
ROIC/WACCN/A
WACCN/A
PLSE Yearly LT Debt VS Equity VS FCFPLSE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

  • PLSE has a Current Ratio of 10.02. This indicates that PLSE is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 10.02, PLSE belongs to the best of the industry, outperforming 92.47% of the companies in the same industry.
  • A Quick Ratio of 10.01 indicates that PLSE has no problem at all paying its short term obligations.
  • The Quick ratio of PLSE (10.01) is better than 93.55% of its industry peers.
Industry RankSector Rank
Current Ratio 10.02
Quick Ratio 10.01
PLSE Yearly Current Assets VS Current LiabilitesPLSE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

0

3. Growth

3.1 Past

  • PLSE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.68%.
EPS 1Y (TTM)-40.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • PLSE is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -35.81% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-26.67%
EPS Next 2Y-35.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PLSE Yearly Revenue VS EstimatesPLSE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2025 2026 1M 2M 3M
PLSE Yearly EPS VS EstimatesPLSE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5 -2

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PLSE. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PLSE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PLSE Price Earnings VS Forward Price EarningsPLSE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PLSE Per share dataPLSE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

  • PLSE's earnings are expected to decrease with -35.81% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-35.81%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for PLSE!.
Industry RankSector Rank
Dividend Yield 0%

PULSE BIOSCIENCES INC / PLSE FAQ

What is the fundamental rating for PLSE stock?

ChartMill assigns a fundamental rating of 2 / 10 to PLSE.


What is the valuation status for PLSE stock?

ChartMill assigns a valuation rating of 0 / 10 to PULSE BIOSCIENCES INC (PLSE). This can be considered as Overvalued.


How profitable is PULSE BIOSCIENCES INC (PLSE) stock?

PULSE BIOSCIENCES INC (PLSE) has a profitability rating of 0 / 10.